New Synthetic Anticoagulant Developed at UNC Ready for Clinical Trials
A new synthetic version of the widely used anticoagulant heparin developed at the University of North Carolina at Chapel Hill can now be made in commercially viable quantities and promises to be safer than existing drugs. It is ready to … Read more